Trial Profile
Dobutamine vs levosimendan in patients with low cardiac output following cardiac surgery
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 11 Jan 2014
Price :
$35
*
At a glance
- Drugs Dobutamine (Primary) ; Levosimendan (Primary)
- Indications Liver dysfunction; Low cardiac output
- Focus Pharmacodynamics
- 11 Jan 2014 New trial record
- 01 Nov 2013 Substudy results published in Anaesthesia and Intensive Care.